98%
921
2 minutes
20
Background: Natriuretic peptide receptor 2 (NPR2) is a crucial regulator of endochondral bone growth. However, patients carrying heterozygous NPR2 gene mutations exhibit a wide range of clinical phenotypes, and evidence regarding treatment efficacy is limited, with the pathogenic mechanisms not yet fully understood. Therefore, the aim of this study is to analyze and identify the clinical phenotypes, treatment outcomes, and pathogenic molecular mechanisms associated with NPR2 gene mutations.
Methods: Through exome sequencing, we sequenced NPR2 in three Chinese Han patients with short stature and validated the results in their families. Clinical characteristics, treatment follow-up analysis, protein 3D structure prediction, in vitro functional experiments, and transcriptome sequencing were used to examine the protein changes caused by the variants, their pathogenicity, and the underlying molecular mechanisms of the disease.
Results: All three patients with NPR2 (p.R318W, p.I908T, p.R976H) gene mutations exhibited non-specific skeletal dysplasia and short stature, with good efficacy of recombinant human growth hormone (rhGH) treatment. Compared to the wild type, the protein expression level of NPR2 mutants was significantly reduced (P < 0.001), and CNP-induced cyclic guanosine monophosphate (cGMP) production was significantly decreased (P < 0.0001). Transcriptome sequencing analysis revealed that Csf2 is a key differentially expressed gene between NPR2 mutant and wild type, and also an upstream regulator of the JAK2-STAT5 pathway. Further validation via qRT-PCR and Western blot showed that NPR2 gene mutations significantly reduced Csf2 gene mRNA expression (P < 0.05), and protein expression of JAK2, p-JAK2, and p-STAT5 was significantly decreased (P < 0.05). Further analysis revealed that NPR2 gene mutations significantly affected the expression of chondrocyte differentiation markers Sox9, Col2A1, and BMP4 (P < 0.001).
Conclusion: Our study provides new insights into the loss of function of NPR2. NPR2 gene mutations may influence the expression and phosphorylation levels of proteins in the JAK2-STAT5 signaling pathway by downregulating Csf2, thereby affecting chondrocyte differentiation and ultimately leading to short stature.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12315304 | PMC |
http://dx.doi.org/10.1186/s13023-025-03936-5 | DOI Listing |
J Hered
August 2025
Department of Ecology & Evolutionary Biology, Princeton University, Princeton, NJ, USA.
Many endangered species rely on ex situ management for survival when external threats exist on the landscape. Yet ex situ settings pose challenges through space limitation, altered environment, and diet. This can lead to environmentally-determined inbreeding depression, where ex situ animals exhibit reduced reproductive fitness compared to their in situ counterparts, despite originating from the same genetic stock.
View Article and Find Full Text PDFOrphanet J Rare Dis
August 2025
Department of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining Medical University, 89 Guhuai Road, Jining, 272029, Shandong, People's Republic of China.
Background: Natriuretic peptide receptor 2 (NPR2) is a crucial regulator of endochondral bone growth. However, patients carrying heterozygous NPR2 gene mutations exhibit a wide range of clinical phenotypes, and evidence regarding treatment efficacy is limited, with the pathogenic mechanisms not yet fully understood. Therefore, the aim of this study is to analyze and identify the clinical phenotypes, treatment outcomes, and pathogenic molecular mechanisms associated with NPR2 gene mutations.
View Article and Find Full Text PDFCurr Opin Pediatr
August 2025
Division of Endocrinology and Center for Genetic Medicine Research, Children's National Hospital.
Purpose Of Review: This review highlights recent genetic discoveries and therapeutic advancements in evaluating and managing children with short stature. With an increasing diagnostic yield from genetic testing and the emergence of genotype-specific treatments, a comprehensive update is necessary for timely application in clinical practice.
Recent Findings: New pathogenic variants have been identified in genes, including FBN1, IHH, NPR2, ACAN, FGFR3, COMP, MATN3, EXT2, and LZTR1, associated with syndromic and nonsyndromic short stature.
Ital J Pediatr
June 2025
Department of Endocrinology, Baoding, NO. 1 Central Hospital, Baoding, Hebei, China.
Background: Acromesomelic dysplasia Maroteaux type (AMDM) is a rare autosomal recessive skeletal dysplasia with an estimated prevalence of 1:1,000,000. It is characterized by extreme shortening of the forelimbs and disproportionate short stature.
Case Presentation: Here we present the clinical and genetic features of an 8-year-8-month-old boy exhibiting idiopathic short stature and abnormal changes of the appendicular skeleton and axial skeleton, consistent with the established phenotypic spectrum of AMDM.